Anavex Life Sciences Corp

Healthcare · Biotechnology

1.60$ -2.7% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Anavex Life Sciences Corp (AVXL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 120 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AVXL
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	9.5	21	24	25	28	28	26	27	24	22	21	22	25	31	31	32	35	54	84	166	162	157	160	160	153	148	159	158	154	148	145	142	136	124	117	102	104	133	129	120
Current Assets	9.4	21	24	25	28	28	26	27	24	22	21	22	25	31	31	32	35	54	84	166	162	157	160	160	153	148	159	158	154	148	145	142	136	124	117	101	104	133	129	120
Cash	9.2	21	23	25	27	28	26	26	23	21	19	21	22	27	27	28	29	47	76	158	152	151	153	153	149	144	153	155	151	144	139	139	132	121	116	101	103	132	127	118
Cash & Short-Term Investments	9.2	21	23	25	27	28	26	26	23	21	19	21	22	27	27	28	29	47	76	158	152	151	153	153	149	144	153	155	151	144	139	139	132	121	116	101	103	132	127	118
Receivables	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	2.6	3.7	4.2	3.5	4.8	6.6	7.3	8.6	9.1	5.4	6.5	6.6	3.2	4.1	4.7	2.2	2.7	3.5	3.8	1.7	2.4	2.6	0.7	0.8	0.8	0.8	0.9	1.0
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	3.2	2.2	2.1	1.5	3.6	2.8	3.4	3.2	3.9	4.9	6.4	4.3	5.0	5.5	6.2	6.9	7.3	8.0	7.8	9.3	11	11	8.1	9.5	10	13	14	11	13	12	9.6	12	15	13	17	11	8.9	6.4	7.1	7.7
Current Liabilities	3.2	2.2	2.1	1.5	3.6	2.8	3.4	3.2	3.9	4.9	6.4	4.3	5.0	5.5	6.2	6.9	7.3	8.0	7.8	9.3	11	11	8.1	9.5	10	13	14	11	13	12	9.6	12	15	13	17	11	8.9	6.4	7.1	7.7
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.1	–	–	–	–	–	–	–	–	–	–	–	–	0.9	-0.9	–	–	–	–	–	–	–	–
Accounts Payable	3.1	2.1	2.0	1.4	3.6	2.8	3.4	3.2	3.0	4.9	6.4	4.3	3.5	3.1	3.6	4.0	4.0	4.2	3.7	4.2	4.7	4.6	2.6	3.1	3.8	5.3	6.3	4.2	4.3	4.3	3.7	3.5	9.6	4.6	7.0	6.7	4.2	2.6	2.5	3.7
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	6.3	19	21	23	24	26	22	24	20	17	14	18	20	26	25	25	27	46	76	157	151	146	152	151	142	135	145	147	142	136	135	130	120	111	100	91	95	127	122	112
Retained Earnings	-78	-81	-83	-86	-91	-96	-100	-103	-109	-116	-124	-131	-133	-140	-147	-154	-160	-168	-176	-186	-198	-208	-219	-231	-246	-259	-272	-283	-293	-302	-312	-324	-336	-348	-359	-373	-382	-388	-393	-386
Shares Outstanding	38	38	41	42	43	44	45	45	46	46	47	50	55	55	58	59	64	64	69	71	76	76	76	77	77	78	78	81	80	82	82	85	84	85	85	85	86	89	93	91

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings